Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/8583
Title: | Effects of topiramate on peripheral nerve excitability | Authors: | Erdogan, Çağdaş Yücel, Mehmet Akgün, H. Kaşkç, T. Semai Bek, V. Gökçil, Z. |
Keywords: | Migraine Nerve conduction Nerve excitability Rheobase Strength duration time Topiramate topiramate adult article clinical article controlled study female human male median nerve migraine nerve conduction nerve excitability nerve stimulation nervous system electrophysiology peripheral nerve Action Potentials Adult Anticonvulsants Electromyography Epilepsy Evoked Potentials, Motor Evoked Potentials, Somatosensory Female Fructose Humans Neural Conduction Peripheral Nerves Wrist |
Abstract: | PURPOSE: Antiepileptic drugs are generally used to control the cortical hyperexcitable states. But some of them are also effective on the peripheral nervous system, so they may be used in some states like neuropathic pain. Several recent reports suggest the possible effects of antiepileptic drugs on peripheral nerve excitability. Strength duration time properties gives an indirect idea about the persistent, paranodal sodium (Na) channels and may indirectly reflect the peripheral nerve excitability. Topiramate suppresses the cortical hyperexcitability, but previous studies could not prove a significant effect of topiramate on peripheral nerves. The aim of this study is to investigate the probable nerve excitability changes caused by topiramate. METHODS: Forty migraine patients and 40 controls were included in the study. Median motor and sensory conduction parameters were recorded. Strength duration properties were also recorded from abductor pollicis longus muscle, with the stimulation of median nerve. The electrophysiological studies were repeated 4 weeks after the initiation of topiramate in the treatment group. RESULTS: Nerve conduction parameters were not significantly affected by 4-week topiramate treatment. But the strength duration time constant decreased significantly, reflecting a reduction in the excitability. This decrement seemed to be more obvious in those in whom topiramate was also clinically useful. CONCLUSIONS: The method used demonstrated a probable effect of topiramate on the peripheral nerve excitability. Copyright © 2012 by the American Clinical Neurophysiology Society. | URI: | https://hdl.handle.net/11499/8583 https://doi.org/10.1097/WNP.0b013e318257c0a0 |
ISSN: | 0736-0258 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
6
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
6
checked on Nov 21, 2024
Page view(s)
32
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.